NLM Digital Collections

Search

Start Over Publication Year 2019 ✖Remove constraint Publication Year: 2019

333. Concerns about opioid use in Medicare Part D in the Appalachian region

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, April 2019
Subject(s):
Analgesics, Opioid -- therapeutic use
Medicare Part D
Opioid-Related Disorders -- epidemiology
Drug Utilization -- statistics & numerical data
Inappropriate Prescribing -- statistics & numerical data
Prescription Drug Diversion -- statistics & numerical data
Prescription Drug Monitoring Programs
Humans
Appalachian Region
United States

334. National Background Check Program for long-term-care providers: assessment of state programs concluded between 2013 and 2016

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, April 2019
Subject(s):
Crime -- prevention & control
Government Programs
Health Personnel -- legislation & jurisprudence
Long-Term Care -- legislation & jurisprudence
Violence -- prevention & control
Criminals
Federal Government
Government Regulation
Home Care Services -- legislation & jurisprudence
Home Health Aides -- legislation & jurisprudence
Mandatory Programs
Nursing Homes -- legislation & jurisprudence
State Government
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

335. One percent of drugs with Medicaid reimbursement were not FDA-approved

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, May 2019
Subject(s):
Drug Approval
Insurance, Health, Reimbursement -- economics
Insurance, Health, Reimbursement -- statistics & numerical data
Medicaid -- economics
Medicaid -- statistics & numerical data
Economics, Pharmaceutical
Fraud -- prevention & control
Prescription Drugs -- economics
Humans
United States
United States. Food and Drug Administration.

338. Most hospitals obtain compounded drugs from outsourcing facilities, which must meet FDA quality standards

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2019
Subject(s):
Drug Compounding -- standards
Medicare
Outsourced Services
Purchasing, Hospital
Quality Control
Chemistry, Pharmaceutical -- standards
Humans
United States
United States. Food and Drug Administration.

339. Part D plans generally include drugs commonly used by dual eligibles: 2019

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2019
Subject(s):
Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Insurance Coverage
Medicare Part D -- economics
Insurance, Pharmaceutical Services -- economics
Medicaid -- economics
Medicare -- economics
Humans
United States
United States.
Centers for Medicare & Medicaid Services (U.S.)